Business Wire

Warehouse TERRADA Forms a Three-Party Partnership with Yokohama University of Art and Design and PALAZZO SPINELLI, an Italian Institute for Art and Restoration

Jaa

Warehouse TERRADA formed a three-party partnership with Tokiwamatsu Gakuen’s Yokohama University of Art and Design and PALAZZO SPINELLI ISTITUTO PER L’ARTE E IL RESTAURO, an institute for art and restoration located in Florence, Italy, concerning the restoration and preservation of cultural heritage in Italy.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180621005372/en/

From left) Emanuele Amodei, President of Palazzo Spinelli / Yasuyuki Korekawa, Operating officer of  ...

From left) Emanuele Amodei, President of Palazzo Spinelli / Yasuyuki Korekawa, Operating officer of Warehouse TERRADA / Nobuaki Okamoto, Chairman of the Board of Directors, Tokiwamatsu Gakuen and President, Yokohama University of Art and Design (Photo: Business Wire)

Warehouse TERRADA has always considered it to be important to educate future professionals involved in the restoration and preservation of artworks and craftworks. We have made a wide-ranging proactive effort in this field, such as by launching a collaborative course in art restoration and preservation at Yokohama University of Art and Design in April 2017, and by establishing TERRADA CONSERVATION LABORATORY in our main office in Tennoz in April 2018.

With this three-party partnership, together with the other two organizations, we will operate educational and vocational training programs in Florence, Italy, which is regarded as home of art restoration, and encourage people-to-people exchanges between Japan and Italy, in order to contribute towards educating and producing future professionals who will lead the art industry as well as cultural heritage conservation. Warehouse TERRADA will continue to improve our art-related services.

[Signing Ceremony for Three-Party Partnership]
Date: May 17th (Thu.), 2018
Location: PALAZZO SPINELLI PER L’ARTE E IL RESTAURO (Florence, Italy)
Participants:
Emanuele Amodei (President of PALAZZO SPINELLI ISTITUTO PER L’ARTE E IL RESTAURO)
Nobuaki Okamoto (Chairman of the Board of Directors, Tokiwamatsu Gakuen / President of Yokohama University of Art and Design)
Yasuyuki Korekawa (Operating officer of Warehouse TERRADA / CEO of TERRADA ART ASSIST Co., Ltd. / Project associate professor of Yokohama University of Art and Design)

[About PALAZZO SPINELLI]
Name: PALAZZO SPINELLI ISTITUTO PER L’ARTE E IL RESTAURO
Representative: President, Emanuele Amodei
Address: Via Maggio, 13 - 50125 Firenze, Italy
Foundation: March 1978
URL: http://www.palazzospinelli.org/eng/default.asp

[About Yokohama University of Art and Design]
Name: Yokohama University of Art and Design
Representative: President, Nobuaki Okamoto
Address: 1204 Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa Prefecture
Foundation: 2010 (The predecessor was the Department of Figurative Art at Tokiwamatsu Gakuen Women’s Junior College, founded in 1966)
URL: http://www.yokohama-art.ac.jp/intl/en/

[About TERRADA CONSERVATION LABORATORY]
Address: 2-6-10 Higashi-Shinagawa, Shinagawa-ku, Tokyo 140-0002, Japan
Main Business: Art Restoration
Operation: TERRADA ART ASSIST Co., Ltd.
URL: https://terrada-art-assist.co.jp/

[About Warehouse TERRADA]
Company Name: Warehouse TERRADA
Main Business: Preservation/Safekeeping Business and Related Business
Representative: CEO, Yoshihisa Nakano
Address: 2-6-10 Higashi-Shinagawa, Shinagawa-ku, Tokyo 140-0002, Japan
Foundation: October 1950
URL: http://www.terrada.co.jp/

Contact information

[For Inquiries about Art Restoration]
TERRADA ART ASSIST Co., Ltd.
+81(0)3-6433-3120
info@terrada-art-assist.co.jp
or
[For Inquiries, Press Only]
Warehouse TERRADA
PR Group
pr@terrada.co.jp

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 17:33Tiedote

Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W

Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations16.11.2018 16:55Tiedote

Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced the addition of specializations to its PartnerConnect Consulting program. Specializations have been added to aid insurance companies in selecting the best partner to lead or staff their Guidewire projects. Guidewire unveiled new specializations, including two which have been successfully piloted earlier this year. “Our customers will now have more clarity and information as to which partners have the proven capabilities in their chosen product and region,” said Lisa Walsh, vice president, Alliances, Guidewire Software. “Adding these specializations will also allow us to have more insight into a partner’s performance and competencies.” To earn a specialization, partners need to demonstrate skills, knowledge, and competency in a specific Guidewire product or solution by certifying staff at multiple levels (specialist and professional) through Guidewire’

Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease16.11.2018 16:15Tiedote

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibitor for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.2 The CHMP’s positive opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the use of apalutamide. The CHMP’s positive opinion is based on data from the pivotal SPARTAN Phase 3 clinical study which assessed the safety and efficacy of apalutamide versus placebo in patients with nmCRPC who have a rapidly rising prostate specific antigen (PSA) level despite receiving continuous androgen deprivation therapy (ADT). The SPARTAN clinical study showed that apalutamide, when added to ADT, significantly reduced the risk

Vertex Receives European CHMP Positive Opinion for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease16.11.2018 15:57Tiedote

Vertex Pharmaceuticals (Europe) Limited today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease. If the European Commission issues a favorable adoption of the EMA CHMP opinion for the extension of indication, lumacaftor/ivacaftor will be the first and only medicine approved in Europe to treat the underlying cause of CF for patients aged 2 to 5 years old who have two copies of the F508del mutation. “Cystic fibrosis is a chronic, progressive disease and it is important to treat early to ensure the best possible outcomes for patients,” said Reshma Kewalramani, MD, Executive Vice President, Global Medicines Development and Medical Affairs and Chief Medical Officer at Vertex. “Today’s announcement brings us one step cl

Dimension Data Global Delivery Centre (GDC) in Prague wins the ABSL 2018 Diamond Award for Business Innovation16.11.2018 11:00Tiedote

Dimension Data, the USD 8 billion global technology integrator and managed services provider, today announced that its Global Delivery Centre (GDC) in Prague has won the 2018 ABSL Diamond award for Business Innovation. The main purpose of this centre is to provide innovative, global service delivery capabilities and deep technical expertise to support our clients. The ABSL Diamond awards recognise companies that implement innovative projects, enhancing their business and strengthening the position of the business services sector. Every year, the aim is to identify successful activities in this sector and promote best practices, ultimately encouraging and inspiring others to follow suit. The ABSL celebrates initiatives that push business services forward and stand out as exemplary projects. Bill Padfield, Group Chief Operating Officer for Transformation and Services at Dimension Data, said: “Winning another award for our Support Services is a fantastic achievement. This time the ABSL Di

FCC Grants LeoSat U.S. Market Access16.11.2018 09:00Tiedote

LeoSat Enterprises, the dynamic young company which is launching a unique new data network comprised of a constellation of up to 108 low-earth-orbit communications satellites, has been awarded the authority by the U.S. Federal Communications Commission (FCC) to provide NGSO (non-geostationary satellite orbit) services in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181115005890/en/ LeoSat's Global Business Backbone in Space (Graphic: Business Wire) The increasing demand for business connectivity and with it, the need to move large quantities of data quickly and securely around the world, is fast outpacing the infrastructure in place to carry it. Existing networks are already carrying more than 1 Zeta Byte of traffic globally and this is set to grow exponentially. The FCC market access grant will allow LeoSat to address currently unmet demand for high-bandwidth, low-latency, high-security data transmissio

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme